Nasdaq:US$12.13 (-0.47) | HKEX:HK$18.98 (-0.42) | AIM:£1.92 (-0.08)
搜索结果
上一篇文章   |   下一篇文章
公告及新闻稿, 其他业务 | 2014-04-17

Chi-Med and Sinopharm complete regulatory approval for the establishment of new China drug distribution and marketing Joint Venture